Table 1

Summary of the study programme

PreoperativeDay 1Day 30Month 3Month 6Month 12Months 24, 36 and 60
Eligibility
Informed consent
Randomisation
Characteristics of patients
EQ-5D questionnaire
SF-36 questionnaire
Judgement criteria
Adverse events
Long-term survival